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The ubiquitous protein Ser/Thr phosphatase-1 (PP1)
interacts with dozens of regulatory proteins that are
structurally unrelated. However, most of them share
a short, degenerate ‘‘RVxF’’-type docking motif.
Using a broad in silico screening based on a stringent
definition of the RVxF motif, in combination with
a multistep biochemical validation procedure, we
have identified 78 novel mammalian PP1 interactors.
A global analysis of the validated RVxF-based PP1
interactome not only provided insights into the
conserved features of the RVxF motif but also led to
the discovery of additional common PP1 binding
elements, described as the ‘‘SILK’’ and ‘‘MyPhoNE’’
motifs. In addition to the doubling of the known
mammalian PP1 interactome, our data contribute to
the design of PP1 interaction networks. Notably, an
interaction network linking PP1 interactors discloses
a pleiotropic role of PP1 in cell polarity.
INTRODUCTION
Several thousands of human proteins have already been found
to be phosphorylated in vivo (Olsen et al., 2006), mostly on
serines or threonines. More than 400 human genes encode
protein Ser/Thr kinases (Manning et al., 2002), but there are
only about 40 genes that encode protein Ser/Thr phosphatases
(Moorhead et al., 2007). This striking imbalance in gene number
can be explained by a different diversification strategy during
evolution. Indeed, protein kinases have mainly diversified by
gene duplication and subsequent specification, whereas protein
Ser/Thr phosphatases have diversified muchmore by increasing
the variety of their regulatory subunits. At the holoenzyme level
protein Ser/Thr kinases and phosphatases are equally diverse
and show a similarly restricted substrate specificity. This is strik-
ingly illustrated by protein phosphatase-1 (PP1), a ubiquitous
and conserved enzyme that is estimated to catalyze about a third
of all protein dephosphorylations in eukaryotic cells (Cohen,
2002; Ceulemans and Bollen, 2004; Moorhead et al., 2007).
The mammalian PP1 isoforms, encoded by three genes, do
not exist freely in the cell but tightly associate with a host of
different proteins that determine when and where the phospha-Chemistry & Biology 16tase acts. PP1 interactors function as activity regulators,
substrate-targeting proteins, substrate specifiers, and/or
substrates. About 100 mammalian PP1 interactors have already
been described and the rate of discovery of novel interactors
shows as of yet no sign of abating, suggesting that many more
interactors remain to be identified.
Using standard sequence analysis, PP1 interacting proteins
do not show an obvious structural similarity because most of
the few known PP1 docking motifs are short and degenerate
(Terrak et al., 2004; Hurley et al., 2007) and flanked by uncon-
served stretches. A majority of the known PP1 interactors
contain a variant of a motif that is now commonly referred to
as the RVxF motif (Egloff et al., 1997; Ceulemans and Bollen,
2004). Crystallographic studies revealed that the RVxF motif
binds as an extended b strand to a hydrophobic groove of PP1
that is 20 A˚ away from the catalytic site (Egloff et al., 1997; Terrak
et al., 2004). Docking of the RVxF motif per se does not have
a major effect on the conformation of the catalytic subunit but
increases the local concentration of the interactor and thereby
promotes secondary interactions that can affect the activity or
substrate specificity of the phosphatase. Largely based on the
conservation of established PP1-interacting RVxF motifs,
Wakula et al. (2003) defined the RVxF motif as a five-residue
motif with the consensus sequence [RK]-X(0,1)-[VI]-{P}-[FW],
where X is any residue and {P} any residue but P. This definition
is sensitive in that it covers about 90% of all known PP1-binding
RVxF variants but lacks specificity because it occurs randomly in
about a quarter of all proteins (Ceulemans and Bollen, 2006).
More recently, Meiselbach et al. (2006) used site-directed muta-
genesis to map the residues that are tolerated at each position of
the RVxF motif and proposed the consensus sequence [HKR]-
[ACHKMNQRSTV]-V-[CHKNQRST]-[FW]. The latter definition
has only a sensitivity of about 40% but displays a 10-fold higher
specificity than the Wakula definition (Ceulemans and Bollen,
2006).
Most PP1 interactors have been identified by classical
biochemical approaches and two-hybrid screens. We have
combined the specific Meiselbach definition and the sensitive
Wakula definition of the PP1-interacting RVxF motif, as well as
additional context filters, in an in silico search for novel PP1 inter-
actors. This has led to the identification of 115 novel candidate
PP1 interactors, 78 of which could be validated using indepen-
dent biochemical approaches. Our study illustrates the feasibility
of a bioinformatics-assisted, proteome-wide screening for struc-
turally unrelated proteins that share a short, degenerate motif., 365–371, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 365
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The Mammalian PP1 InteractomeFigure 1. Biochemical Validation of the Interaction of Proteins with PP1
(A) Affinity-purified His-tagged fragments of the indicated proteins were used for pull-down experiments with GST-PP1a and GST. The His-tagged fragments in
the mixture (input) and the precipitates were visualized by immunoblotting with anti-His antibodies. The figure shows representative data for proteins that were
validated as PP1 interactors.366 Chemistry & Biology 16, 365–371, April 24, 2009 ª2009 Elsevier Ltd All rights reserved
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In Silico Screening for Novel PP1 Interactors
The screening was performed on 14,725 sets of orthologous
human, mouse, and rat protein sequences, obtained by an all-
against-all BLASTP analysis. Because multiple sets can derive
from a single gene, these 14,725 sets correspond to just over
14,000 genes or about two thirds of the protein encoding
genome. Out of the 14,725 orthologous sets, 397 contained an
RVxF variant that was conserved in all three species and
compatible with both the sensitive Wakula definition and the
specific Meiselbach definition (Wakula et al., 2003; Meiselbach
et al., 2006). This screening thus excluded proteins, such as
Inhibitor-2, that have a RVxF motif that does not conform to
both definitions. The list of predicted PP1 interactors was further
reduced using additional filters. First, since the RVxF motif is
known to be present in a flexible loop that adopts a b strand
conformation upon binding to PP1 (Egloff et al., 1997), proteins
with an RVxF variant in a globular domain were removed from
the list. Second, since PP1 only exists intracellularly, proteins
with a consensus RVxF motif in an extracellular or transmem-
brane domain were considered to be false positives. Third, 22
sets represented already known PP1 interactors and they were
not further analyzed. Altogether, these additional filters reduced
the number of novel candidate interactors of PP1 to 115 (see
Table S1 available online).
Validation of the Interaction with PP1
To biochemically validate the interaction with PP1, we first ex-
pressed fragments of the putative interactors as His-tagged
fusion proteins in bacteria and affinity purified the fusions on
Ni2+-Sepharose. The fragments were about 200 residues on
average with the RVxF motif in the middle, as detailed in Table
S1. This expression and purification approach succeeded for
103 out of the 115 predicted interactors. The purified proteins
were tested for their ability to bind PP1 in pull-down assays
with glutathione S-transferase (GST)-tagged PP1a (Figures 1A
and 2). GST served as a negative control. Conversely, the His-
tagged fusions, bound to Ni2+-Sepharose, were incubated with
the purified catalytic subunit of PP1 and the retained phospha-
tase activity was quantified with glycogen phosphorylase a as
substrate, after prior trypsinolysis to release the fully active cata-
lytic subunit (Figures 1B and 2). In the latter assays, the estab-
lished PP1 interactor His-eIF2b was used as a positive controlChemistry & Biology 16and His-eIF2b with a mutated RVxF motif as a negative control
(Wakula et al., 2006). Both tests yielded essentially the same
results and validated 78 out of the 103 tested proteins as
in vitro interactors of PP1. Because many PP1 interactors are
inhibitory with exogenous substrates (Bollen, 2001), we also
examined the effect of the novel interactors on the phosphory-
lase phosphatase activity of PP1. More than half of these
proteins (i.e., 49 out of 78) were inhibitory (Figures 1C and 2),
which represents additional and independent biochemical
evidence for their interaction with PP1 and is suggestive for their
role as activity regulators or substrate specifiers. However,
because the effects of PP1 interactors are substrate dependent,
their exact function can only be explored once the substrates of
the corresponding holoenzymes are known. The biochemical
validation tests shown in Figures 1A–1C were also used for five
previously established PP1 interactors and five randomly chosen
proteins (Figure S1). In these tests, the first five proteins were
confirmed as PP1 interactors while the randomly chosen
proteins were all negative, attesting to the specificity and sensi-
tivity of the adopted assays. It is also worthy of note that 16
paralogs of the 78 novel and validated human PP1 interactors
also had an RVxF(-like) motif at the same position (Table S2).
Although these paralogs were not retained during the initial
in silico screening with the adopted filters they are also possible
PP1 interactors.
It could be argued that the detected in vitro interaction with
PP1 (Figures 1A–1C and 2) is artifactual and results from the
use of protein fragments. Therefore, we expressed 21 of the vali-
dated PP1 interactors as full-length proteins with an N-terminal
enhanced green fluorescent protein (EGFP) tag in HEK293 cells
and immunoprecipitated the fusion proteins with anti-EGFP
antibodies (Figure 1D and data not shown). Of the 21 examined
proteins, 17 coimmunoprecipitated with endogenous PP1, as
detected by immunoblotting with PP1 antibodies (Figures 1E
and 2) and by the assay of trypsin-revealed phosphorylase
phosphatase activity (Figures 1F and 2). The immunoprecipi-
tated interactors were also used for overlay assays with purified
GST-PP1a after SDS-PAGE (Figures 1G and 2). In the latter
assays, 18 out of the 21 tested proteins bound GST-PP1a, but
not GST. Importantly, GST-PP1a was not retained when satu-
rated with a synthetic RVxF peptide, indicating that the binding
to the interactors was specific and depended on an accessible
RVxF-binding channel. Collectively, these experiments with
full-length proteins largely confirmed the data obtained with(B) The His-tagged interactor fragments, bound to Ni2+-Sepharose, were incubated with purified PP1. The retained PP1 was quantified by the assay of the
trypsin-revealed phosphorylase phosphatase activity. eIF2b served as a positive control and eIF2b with a mutated RVxF motif (eIF2bm) as a negative control.
The phosphatase activities (bars) are expressed as means ± SEM (n = 3). *p < 0.05, as compared to the value with eIF2bm (paired t test).
(C) Effects of the indicated affinity-purified interactor fragments on the phosphorylase phosphatase activity of purified PP1. The activities are expressed as
means ± SEM (n = 3).
(D) The indicated proteins were expressed as EGFP-tagged fusions in HEK293 cells and immunoprecipitated with anti-EGFP antibodies, as verified by
immunoblotting.
(E) The coimmunoprecipitated endogenous PP1 was detected by immunoblotting with anti-PP1 antibodies.
(F) The coimmunoprecipitated PP1was also quantified (gray bars) by the assay of the trypsin-revealed phosphorylase phosphatase activity (means ± SEM; n = 3).
*p < 0.05 (paired t test), as compared to the value without primary antibodies (hatched bars).
(G) In addition, the immunoprecipitated proteins were processed for SDS-PAGE, blotted, and incubated with GST-PP1a, GST-PP1a that was saturated with
a synthetic RVxF peptide, or GST. The retained GST (fusion) was visualized with anti-GST antibodies.
(H) Subcellular localization of transiently expressed EGFP-Fam130A1, EGFP-Fam130A1 with a mutated RVxF motif (EGFP-Fam130A1m), and RFP-PP1g in
HEK293 cells, as detected by fluorescence microscopy.
(I) EGFP-Fam130A1wt (top) or EGFP-Fam130A1m (bottom) were coexpressedwith RFP-tagged PP1g. The figure shows the subcellular localization of RFP-PP1g
(left), EGFP-Fam130A1wt and m(utant) (middle), and the merged pictures (right). Size bar: 10 mm., 365–371, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 367
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The Mammalian PP1 Interactomethe interactor fragments (see Figure 2 for a detailed comparison
of all validation tests). That not all full-length proteins could be
shown to interact with PP1 is not surprising since this interaction
can be cell type and context dependent (Bollen, 2001; Ceule-
mans and Bollen, 2004).
Whenoverexpressed,somePP1interactorscauseasubcellular
redistribution of endogenous PP1 (Lesage et al., 2004). We have
used this in situ test of PP1 interaction for two of the newly identi-
fied PP1 interactors, namely Fam130A1 (Figures 1H and 1I) and
ELL (Figure S2). Fam130A1 displayed a uniform nuclear distribu-
tion but was excluded from the nucleoli, while ELL showed
a speckled nuclear distribution, consistent with its described
association with the Cajal bodies (Polak et al., 2003). The expres-
sion of EGFP-tagged fusions of Fam130A1 or ELL caused
a subnuclear redistribution of coexpressed red fluorescent
protein (RFP)-tagged PP1g in that it lost its characteristic nucle-
Figure 2. Novel Interactors of PP1
(A) All listed genes encode proteins that interact
with PP1, as tested with His-tagged fragments in
GST pull-down experiments (see Figure 1A) and
PP1 retention assays on Ni2+-Sepharose (see
Figure 1B). A subset of the interactors were also
expressed as EGFP-tagged full-length proteins
and tested for their ability to coimmunoprecipitate
endogenous PP1 (see Figures 1E and 1F) and to
bind PP1 in overlay assays (see Figure 1G).
(B) The left diagram illustrates the extent to which
the predicted PP1 interactors were validated using
biochemical assays with interactor fragments.
Predicted interactors (115), tested interactors
(103), interactors validated with GST-PP1a pull-
down assays and PP1 retention assays on Ni2+-
Sepharose (78), and fragments that were inhibitory
to PP1, using glycogen phosphorylase as
a substrate (49). The diagram at the right
compares the validation results for full-length
interactors following their transient expression in
HEK293 cells. Tested proteins (21), coimmunopre-
cipitation with endogenous PP1 (17), and overlay
with GST-PP1 (18).
olar enrichment and colocalized with the
EGFP fusions. This altered distribution of
RFP-PP1g was not seen following the
expression of Fam130A1 or ELL with
a mutated RVxF motif (V and F to A), at-
testing to the importanceof thisPP1dock-
ing motif for the redistribution of PP1g.
The Identification of Additional
Common PP1 Interaction Motifs
Currently, we know of 143 mammalian
genes encoding PP1 interactors with
a validated RVxF motif. These comprise
65 previously described PP1 interactors
(Table S3) and the 78 novel interactors
listed in Figure 2A. We have used this
expanded PP1 interactome to reevaluate
the conserved features of the RVxF motif
and its flanking residues (Table S4).
Consistent with a previous proposal (Egloff et al., 1997; Wakula
et al., 2003), the RVxF motif is actually a 5 residue motif. It has
the sequence [K55R34][K28R26][V94I6]{FIMYDP}[F83W17] (see
Table S4 for a more detailed definition), where the numbers in
subscript refer to the percentages of residue occurrence and
braced residues are excluded. The most conserved residues
are those at positions 1, 3, and 5. Interestingly, while some
residues (FIMYDP) never occur at position 4, this position is
clearly enriched for R (17%), K (11%), S (21%), and T (18%).
The enrichment for S and T probably serves a regulatory function
asphosphorylation at this position is known to disrupt the binding
of PP1 (Egloff et al., 1997). Another striking feature is the overrep-
resentation of basic and acidic residues at N-terminal and
C-terminal positions to the RVxF motif, respectively.
Since PP1 interactor complexes often have multiple binding
sites, we have subsequently examined whether the RVxF-based368 Chemistry & Biology 16, 365–371, April 24, 2009 ª2009 Elsevier Ltd All rights reserved
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The Mammalian PP1 InteractomePP1 interactome also shares other well-defined PP1 binding
elements. Themyosin phosphatase targeting subunit Mypt1, en-
coded by ppp1r12a, has an N-terminal PP1 interactionmotif with
the consensus sequence RxxQ[VIL][KR]x[YW] that is involved in
substrate recognition (Terrak et al., 2004). Interestingly, this
motif, coined the myosin phosphatase N-terminal element or
‘‘MyPhoNE,’’ is also present in six other PP1 interactors, always
N-terminal to the RVxF motif (Table 1).
One of the PP1 docking motifs of Inhibitor-2 conforms to the
consensus sequence [GS]IL[RK] (Huang et al., 1999; Wakula
et al., 2003; Hurley et al., 2007) and is here referred to as the
‘‘SILK’’ motif. The SILK motif is essential for potent inhibition
by Inhibitor-2 (Huang et al., 1999; Connor et al., 2000) and can
functionally replace the RVxF motif in NIPP1 (Wakula et al.,
2003). We found that the SILK motif also occurs in six other PP1
interactors and is always N-terminal to the RVxF motif (Table 1).
To delineate the relative importance of the SILK and RVxFmotifs
for PP1 binding we mutated these motifs, either alone or
combined, in SIPP1 and Fam130A1, and examined the effect
of these mutations on the binding of PP1 (Figure S3). For
SIPP1, mutation of either the SILK or the RVxF motif already
drastically reduced the interaction with PP1. In contrast, muta-
tion of the SILK motif in Fam130A1 only had a measurable effect
on PP1 binding when combined with a mutation of the RVxF
motif. These data suggest that the importance of the SILK motif
for the anchoring of PP1 is interactor dependent.
The Design of PP1 Interaction Networks
The identification of 78 novel PP1 interactors, which roughly
represents a doubling of the known mammalian PP1 interac-
tome, facilitates the literature-assisted design of PP1 networks
and yields new insights into the functional diversity of PP1.
This is illustrated in Figure 3 for a ‘‘cell polarity’’ network, which
comprises seven previously identified and nine novel PP1 inter-
Table 1. Additional Common PP1 Binding Motifs in Interactors
with a Validated RVxF Motif
Gene Name MyPhoNE RVxF
myo16 24RCEQIKAY (22) PKVHF58
ppp1r12a 10RNEQLKRW (16) TKVKF38
ppp1r12b 19RAEQLRRW (25) PRVRF56
ppp1r16a 30RAQQVKMW (27) KQVLF69
ppp1r16b 30RAQQLKKW (24) KKVSF66
sh2d4a 32REEQIRRW (24) KSVHW68
sh2d4b 32REEQLRRW (26) KHIQW70
Gene Name SILK RVxF
casc5 25SILK (28) RRVSF61
c1orf71 621SILK (19) RRVRF648
fam130a1 53SILK (7) KNVRF68
fam130a2 52SILK (7) KNVHF67
ppp1r2 13GILK (26) KSQKW47
sytl2 271GILK (55) KHVRF334
wbp11 165SILK (48) RKVGF221
The superscript numbers refer to the position of the residue. The numbers
in parentheses represent the number of residues between the two PP1
binding motifs.Chemistry & Biology 16,actors. This network shows how the PP1 interactome is con-
nected to signaling by the GTPases Cdc42, Rac, and Rho. It
suggests that PP1 sides consistently with Cdc42 and Rac, in
opposition of a cascade of protein kinases allied with Rho. PP1
thereby supports cell growth, cellular protrusions and adhe-
sions, and the response to hypotonicity. The observed alliance
of PP1 with Cdc42 and Rac offers a biological framework for
the generation of functional hypotheses about novel PP1 inter-
actors. For example, like the PP1-binding kinetochore protein
Casc5, Cdc42 has been implicated in the capture of microtu-
bules at the kinetochore (Yasuda et al., 2004). PP1 recruitment
to centrosomal proteins like Nek2A (Mi et al., 2007) or the PP1
interactors Sfi1 and Cep192 (this work) may hint at additional
functions of PP1 in microtubule organization. The interaction of
PP1 with Vps54 or the synaptotagmin-like protein Sytl2 may fit
in nicely with the established role of Cdc42 in exo- and endocy-
tosis (Yu and Bement, 2007). In yeast, Arf1 and Arf2 and the
related protein Bni4 recruit PP1 to the Cdc42-orchestrated
septin ring at the bud neck and the base of mating protrusions,
respectively (Larson et al., 2008). The related vertebrate Phactrs
also bind PP1 and may hence target PP1 to the incipient cytoki-
netic cleavage furrow. In many of these cases, a placement of
novel PP1 interactors in the Cdc42 framework will add tentative
direction to the functional effects of the interaction.
SIGNIFICANCE
The bioinformatics-assisted screening tools that we have
used to search for PP1 interactors can be easily adapted
to identify any group of proteins that share a short, degen-
erate binding motif. Examples include substrates of calci-
neurin with the PxIxIT-type docking motif (Roy et al., 2007)
and proteins with the RFxV-type kinase docking motif (Vitari
et al., 2006). However, the biochemical validation of the
predicted interactions is equally important and the proce-
dures that we have used can not necessarily be applied to
other groups of proteins. For example, we have extensively
made use of interactor fragments that were delineated
rather arbitrarily, without taking into consideration the
protein domain structure. This approach clearly did not
hamper PP1 interaction, probably because the RVxF motif,
and possibly also other PP1 binding domains, show little
3D structure in their unbound form (Dancheck et al., 2008),
butmay be problematic when used for the validation of other
protein-protein interactions.
EXPERIMENTAL PROCEDURES
In Silico Analysis
As a source of maximally comprehensive yet minimally redundant sequence
sets for human, mouse, and rat proteins, we downloaded for each of these
species set 3.13 of the International Protein Index (ftp://ftp.ebi.ac.uk/pub/
databases/IPI/). The 57,032 human, 50,489 mouse, and 39,474 rat sequences
were compared in all-against-all BLASTP searches, using a Perl script with the
database size parameter (z) set to 100,000,000, the low-complexity filtering
flag (F) switched on, and otherwise default parameters. A second Perl script
assembled the 14,725 orthologous sets of reciprocal best BLASTP hits among
the three studied species and filtered them for the presence in all three
sequences of at least one instance that fitted with both theWakula andMeisel-
bach definition of the RVxF-type PP1 docking motif (Wakula et al., 2003;
Meiselbach et al., 2006).365–371, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 369
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The Mammalian PP1 InteractomeFigure 3. An Interaction Network that Links PP1 to Cell Polarity
The network was composed based on published data, with previously described (blue rectangles) and novel (green rectangles) interactors of PP1. The arrows
indicate known kinase substrates.Biochemical Validation of the Interaction with PP1
The bacterially expressed polyhistidine-tagged interactor fragments (Supple-
mental Experimental Procedures and Tables S1 and S5) were used for
pull-down experiments with Ni2+-Sepharose and as inhibitors of the phosphor-
ylase phosphatase activity of PP1 (Wakula et al., 2006). The catalytic subunit of
PP1 was purified from rabbit skeletal muscle and is a mixture of all three
isoforms (DeGuzman and Lee, 1988). For the GST pull-down assays, equi-
molar amounts of GST and GST-PP1a were preincubated for 1 hr at 10C
with glutathione agarose. These precoupled GST and GST-PP1a matrices
were incubated with the His fragments for 1 hr. The precipitates were analyzed
by immunoblotting with anti-His antibodies. For the overlay with GST-PP1a,
the immunoprecipitated proteins were processed for SDS-PAGE and blotted
on polyvinylidene fluoride membranes. The blot was blocked with BSA and
incubated overnight with GST-PP1a, GST-PP1a saturated with 100 mM of
the synthetic RVxF peptide NIPP1 (197–206), or GST alone. Finally, the bound
PP1 was visualized using anti-GST antibodies. HEK293T cells were cultured
and transfected as described previously (Lesage et al., 2004).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, three
figures, and five tables and can be found with this article online at http://
www.cell.com/chemistry-biology/supplemental/S1074-5521(09)00079-9.
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